SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about outcome of board meeting

04 Mar 2020 Evaluate

This is in reference to letter  dated  29  February  2020  intimating  the  date  of  the  Board  Meeting  for consideration of Appointment of Chief Financial Officer (CFO) of the Company. Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the Appointment of Sahil Shah as a Chief  Financial Officer (KMP) the  Company with effect  from  01 March  2020.  The details required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as enclosed. The company has attached Press Release issued in this regard.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1496.95 4.15 (0.28%)
20-Apr-2026 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.75
Dr. Reddys Lab 1233.95
Cipla 1231.60
Zydus Lifesciences 938.70
Lupin 2328.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×